Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 208

1.

A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes expanding the repertoire of potential immunotherapeutic targets.

Taguchi A, Taylor AD, Rodriguez J, Celiktas M, Liu H, Ma X, Zhang Q, Wong CH, Chin A, Girard L, Behrens C, Lam WL, Lam S, Minna JD, Wistuba II, Gazdar AF, Hanash SM.

Cancer Res. 2014 Jun 26. pii: canres.3725.2013. [Epub ahead of print]

PMID:
24970476
[PubMed - as supplied by publisher]
2.

Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer.

Mao J, Ladd J, Gad E, Rastetter L, Johnson MM, Marzbani E, Childs JS, Lu H, Dang Y, Broussard E, Stanton SE, Hanash SM, Disis ML.

J Transl Med. 2014 May 10;12:121. doi: 10.1186/1479-5876-12-121.

PMID:
24886063
[PubMed - in process]
Free PMC Article
3.

Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases.

Prentice RL, Zhao S, Johnson M, Aragaki A, Hsia J, Jackson RD, Rossouw JE, Manson JE, Hanash SM.

Genome Med. 2013 Dec 27;5(12):112. doi: 10.1186/gm517. eCollection 2013.

PMID:
24373343
[PubMed]
Free PMC Article
4.

Mouse to human blood-based cancer biomarker discovery strategies.

Hanash SM, Taguchi A.

Cold Spring Harb Protoc. 2014 Feb 1;2014(2):144-9. doi: 10.1101/pdb.top078808.

PMID:
24173314
[PubMed - in process]
5.

A novel soluble form of Tim-3 associated with severe graft-versus-host disease.

Hansen JA, Hanash SM, Tabellini L, Baik C, Lawler RL, Grogan BM, Storer B, Chin A, Johnson M, Wong CH, Zhang Q, Martin PJ, McDonald GB.

Biol Blood Marrow Transplant. 2013 Sep;19(9):1323-30. doi: 10.1016/j.bbmt.2013.06.011. Epub 2013 Jun 17.

PMID:
23791624
[PubMed - indexed for MEDLINE]
6.

Fibulin-2 is a driver of malignant progression in lung adenocarcinoma.

Baird BN, Schliekelman MJ, Ahn YH, Chen Y, Roybal JD, Gill BJ, Mishra DK, Erez B, O'Reilly M, Yang Y, Patel M, Liu X, Thilaganathan N, Larina IV, Dickinson ME, West JL, Gibbons DL, Liu DD, Kim MP, Hicks JM, Wistuba II, Hanash SM, Kurie JM.

PLoS One. 2013 Jun 10;8(6):e67054. doi: 10.1371/journal.pone.0067054. Print 2013.

PMID:
23785517
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Enrichment strategies in glycomics-based lung cancer biomarker development.

Ruhaak LR, Nguyen UT, Stroble C, Taylor SL, Taguchi A, Hanash SM, Lebrilla CB, Kim K, Miyamoto S.

Proteomics Clin Appl. 2013 May 3. doi: 10.1002/prca.201200131. [Epub ahead of print]

PMID:
23640812
[PubMed - as supplied by publisher]
8.

Identification of potential glycan cancer markers with sialic acid attached to sialic acid and up-regulated fucosylated galactose structures in epidermal growth factor receptor secreted from A431 cell line.

Wu SL, Taylor AD, Lu Q, Hanash SM, Im H, Snyder M, Hancock WS.

Mol Cell Proteomics. 2013 May;12(5):1239-49. doi: 10.1074/mcp.M112.024554. Epub 2013 Jan 31.

PMID:
23371026
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Imaging a functional tumorigenic biomarker in the transformed epithelium.

LeBeau AM, Lee M, Murphy ST, Hann BC, Warren RS, Delos Santos R, Kurhanewicz J, Hanash SM, VanBrocklin HF, Craik CS.

Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):93-8. doi: 10.1073/pnas.1218694110. Epub 2012 Dec 17.

PMID:
23248318
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Unleashing the power of proteomics to develop blood-based cancer markers.

Taguchi A, Hanash SM.

Clin Chem. 2013 Jan;59(1):119-26. doi: 10.1373/clinchem.2012.184572. Epub 2012 Oct 24. Review.

PMID:
23099557
[PubMed - indexed for MEDLINE]
Free Article
11.

Linker for activation of T-cell family member2 (LAT2) a lipid raft adaptor protein for AKT signaling, is an early mediator of alkylphospholipid anti-leukemic activity.

Thomé CH, dos Santos GA, Ferreira GA, Scheucher PS, Izumi C, Leopoldino AM, Simão AM, Ciancaglini P, de Oliveira KT, Chin A, Hanash SM, Falcão RP, Rego EM, Greene LJ, Faça VM.

Mol Cell Proteomics. 2012 Dec;11(12):1898-912. doi: 10.1074/mcp.M112.019661. Epub 2012 Sep 22.

PMID:
23001822
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study.

Li CI, Mirus JE, Zhang Y, Ramirez AB, Ladd JJ, Prentice RL, McIntosh MW, Hanash SM, Lampe PD.

Breast Cancer Res Treat. 2012 Sep;135(2):611-8. doi: 10.1007/s10549-012-2204-4. Epub 2012 Aug 19.

PMID:
22903690
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera.

Lu H, Ladd J, Feng Z, Wu M, Goodell V, Pitteri SJ, Li CI, Prentice R, Hanash SM, Disis ML.

Cancer Prev Res (Phila). 2012 Aug;5(8):1036-43. doi: 10.1158/1940-6207.CAPR-11-0558. Epub 2012 Jun 19.

PMID:
22715141
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer.

Amon LM, Pitteri SJ, Li CI, McIntosh M, Ladd JJ, Disis M, Porter P, Wong CH, Zhang Q, Lampe P, Prentice RL, Hanash SM.

Cancer Res. 2012 Apr 15;72(8):1935-42. doi: 10.1158/0008-5472.CAN-11-3266. Epub 2012 Feb 24.

PMID:
22367215
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.

Press JZ, Reyes M, Pitteri SJ, Pennil C, Garcia R, Goff BA, Hanash SM, Swisher EM.

Int J Gynecol Cancer. 2012 May;22(4):546-52. doi: 10.1097/IGC.0b013e318241d9b9.

PMID:
22315094
[PubMed - indexed for MEDLINE]
16.

Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women.

Ladd JJ, Busald T, Johnson MM, Zhang Q, Pitteri SJ, Wang H, Brenner DE, Lampe PD, Kucherlapati R, Feng Z, Prentice RL, Hanash SM.

Cancer Prev Res (Phila). 2012 Apr;5(4):655-64. doi: 10.1158/1940-6207.CAPR-11-0412. Epub 2012 Jan 25.

PMID:
22277732
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Why have protein biomarkers not reached the clinic?

Hanash SM.

Genome Med. 2011 Oct 26;3(10):66. doi: 10.1186/gm282. No abstract available.

PMID:
22030259
[PubMed]
Free PMC Article
18.

Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.

Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong CH, Wang H, Ungewiss C, Ahn YH, Shin DH, Kurie JM, Hanash SM.

Cancer Res. 2011 Dec 15;71(24):7670-82. doi: 10.1158/0008-5472.CAN-11-0964. Epub 2011 Oct 10.

PMID:
21987723
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.

Taguchi A, Politi K, Pitteri SJ, Lockwood WW, Faça VM, Kelly-Spratt K, Wong CH, Zhang Q, Chin A, Park KS, Goodman G, Gazdar AF, Sage J, Dinulescu DM, Kucherlapati R, Depinho RA, Kemp CJ, Varmus HE, Hanash SM.

Cancer Cell. 2011 Sep 13;20(3):289-99. doi: 10.1016/j.ccr.2011.08.007.

PMID:
21907921
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression.

Pitteri SJ, Kelly-Spratt KS, Gurley KE, Kennedy J, Buson TB, Chin A, Wang H, Zhang Q, Wong CH, Chodosh LA, Nelson PS, Hanash SM, Kemp CJ.

Cancer Res. 2011 Aug 1;71(15):5090-100. doi: 10.1158/0008-5472.CAN-11-0568. Epub 2011 Jun 8.

PMID:
21653680
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk